Skip to content

Is There an Interaction Between Recurrent Miscarriage and Dental Health

Dental Health in Recurrent Miscarriage

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03577314
Enrollment
100
Registered
2018-07-05
Start date
2018-04-15
Completion date
2019-05-15
Last updated
2018-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Miscarriage, Oral Health

Brief summary

Oral infections can trigger the production of pro-inflammatory mediators that may be risk factors for miscarriage. The investigators investigated whether oral health care patterns that may promote or alleviate oral inflammation were associated with the history of miscarriage in Turkish women.

Detailed description

Power analysis was performed with the G-Power software package to determine sample size. To cover possible data loss, 10% of a group were added to each group. Medical and dental examination will be performed both of control and experimental groups. In dental examination decayed, missing, or filled teeth (DMFT) index will be used according to World Health Organization (WHO 1997) criteria. All teeth were visually using the International Caries Detection and Assessment System (ICDAS-II). To analyze the correlation between oral health status and miscarriage linear regression test and for comparison of both the groups (case and control), two sample t test and chi square test were used.

Interventions

OTHERmiscarriage

(ORTHOPANTOMOGRAPH® OP300 PANORAMIC, Instrumentarium Dental, Tuusula, Finland,63 kVp, 0.8 mA, 0.5 s).

Sponsors

Recep Tayyip Erdogan University Training and Research Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* history of at least two unexplained recurrent miscarriage below 20th week of pregnancy * systemically healthy females with at least two normal births * no poor obstetric history such as preeclampsia and premature birth

Exclusion criteria

* history of thyroid disease, hyperprolactinemia, antiphospholipid syndrome, systemic lupus erythematosus, autoimmune diseases, thrombophilia, diabetes mellitus, uterine/cervical abnormalities, polycystic ovary syndrome, active liver disease, cardiovascular disease, premature ovarian failure, acute or chronic upper respiratory tract diseases, IVF pregnancy, multiple pregnancy, preeclampsia, arterial or venous embolism, infection, * habit of smoking, alcohol, drug or caffeine, * abnormal embryo karyotype, * infection with hepatitis B or C, and HIV, * chromosomal abnormalities, * dental fluorosis, * fluoride supplements, * orthodontic appliances, * body mass index ≥ 30 kg / m2 * age of the partner is found to be over 40

Design outcomes

Primary

MeasureTime frameDescription
recurrent miscarriagebelow 20th week of pregnancyIf abortion material is obtainable, it will be genetically evaluated for chromosomal abnormalities. At least 8 weeks after termination of pregnancy, karyotype analysis of both couples and thrombophilia panel ( Factor V Leiden, prothrombin gene mutation G20210A, protein S/Protein C/antithrombin deficiency and MTHFR mutations) in the study group will be requested.

Secondary

MeasureTime frameDescription
Periodontal Examination1 DayA single calibrated examiner measured probing depth-PD, 0: healthy 1. bleeding 2. calculus 3:3.5-5.5 mm 4: over 5.5 mm
Clinical attachment level1 DayA single calibrated examiner measured clinical attachment level- CAL, 0: 0-3 mm 1:4-5 mm 2:6-8 mm 3:over 8mm 4: 9-11 mm 5: over 12 mm
Dental Examination1 DayAll teeth were visually using the International Caries Detection and Assessment System (ICDAS-II). The chosen sites were recorded as: 0 = sound; 1. = first visible sign of noncavitated lesion seen only when the tooth is dried; 2. = visible noncavitated lesion seen when wet and dry; 3. = microcavitation in enamel; 4. = noncavitated lesion extending into dentine seen as an undermining shadow; 5. = small cavitated lesion with visible dentine: less than 50% of surface; 6. = large cavitated lesions with visible dentine in more than 50% of the surface.
Gingival Examination1 DayA single calibrated examiner measured gingival indices (GI) 0= Normal gingiva; 1. Mild inflammation 2. Moderate inflammation 3. Severe inflammation
Bleeding Examination1 DayA single calibrated examiner measured bleeding on probing (BOP) 0: no bleeding 1: bleeding
Plaque Examination1 DayA single calibrated examiner measured plaque (Pl) 0:no plaque 1. A film of plaque 2. soft deposit s within the gingival pocket 3. Abundance of soft matter within the gingival pocket

Countries

Turkey (Türkiye)

Contacts

Primary ContactGül Yıldız Telatar, Dr.
gulyildiz@gmail.com05365404555
Backup ContactBeril Gürlek, Dr.
berilsem@yahoo.com05535979403

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026